Molecular therapy drives patient-centric health care paradigms
Clin Transl Sci
.
2010 Aug;3(4):170-1.
doi: 10.1111/j.1752-8062.2010.00203.x.
Authors
Scott A Waldman
1
,
Andre Terzic
Affiliation
1
Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. scott.waldman@jefferson.edu
PMID:
20718817
PMCID:
PMC2946388
DOI:
10.1111/j.1752-8062.2010.00203.x
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Delivery of Health Care / trends*
Global Health*
Humans
Molecular Targeted Therapy / trends*
Precision Medicine / trends*
Grants and funding
R01 CA075123-07/CA/NCI NIH HHS/United States
R01 CA095026/CA/NCI NIH HHS/United States
R01 CA075123/CA/NCI NIH HHS/United States
R01 CA095026-06/CA/NCI NIH HHS/United States
RC1 CA146033-01/CA/NCI NIH HHS/United States
P30 CA056036/CA/NCI NIH HHS/United States
P30 CA056036-059014/CA/NCI NIH HHS/United States
RC1 CA146033/CA/NCI NIH HHS/United States